In vitro activities of fosfomycin and carbapenem combinations against carbapenem non-susceptible Escherichia coli and Klebsiella pneumoniae

International Journal of Antimicrobial Agents

Volumn 35, Issue 6, 2010, Pages 609-610

  Netikul, Thidarat ^a   Leelaporn, Amornrut ^a   Leelarasmee, Amorn ^a   Kiratisin, Pattarachai ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; DORIPENEM; ERTAPENEM; FOSFOMYCIN; IMIPENEM; MEROPENEM;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DISK DIFFUSION; ESCHERICHIA COLI; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; CARBAPENEMS; DRUG RESISTANCE, BACTERIAL; DRUG SYNERGISM; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FOSFOMYCIN; HOSPITALS; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS;

EID: 77951769252     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.01.021     Document Type: Letter

References (7)

1. Borer A., Saidel-Odes L., Riesenberg K., Eskira S., Peled N., Nativ R., et al. Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia. Infect Control Hosp Epidemiol 2009, 30:972-976.
2. Falagas M.E., Maraki S., Karageorgopoulos D.E., Kastoris A.C., Mavromanolakis E., Samonis G. Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin. Int J Antimicrob Agents 2010, 35:240-243.
3. Roussos N., Karageorgopoulos D.E., Samonis G., Falagas M.E. Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections. Int J Antimicrob Agents 2009, 34:506-515.
4. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Nineteenth informational supplement. Document M100-S19. Wayne, PA: CLSI; 2009.
5. Navon-Venezia S., Chmelnitsky I., Leavitt A., Schwaber M.J., Schwartz D., Carmeli Y. Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel. Antimicrob Agents Chemother 2009, 50:3098-3101.
6. White R.L., Burgess D.S., Manduru M., Bosso J.A. Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test. Antimicrob Agents Chemother 1996, 40:1914-1918.
7. Eliopoulos G.M., Moellering R.C. Antimicrobial combinations. Antibiotics in laboratory medicine 1996, 330-396. Williams & Wilkins, Baltimore, MD. 4th ed. V. Lorian (Ed.).